Angiotensin I-converting enzyme inhibitory activity and antioxidant capacity of bioactive peptides derived from enzymatic hydrolysis of buffalo milk proteins

2017 ◽  
Vol 66 ◽  
pp. 91-98 ◽  
Author(s):  
Mahmoud Abdel-Hamid ◽  
Jeanette Otte ◽  
Cristian De Gobba ◽  
Ali Osman ◽  
Essam Hamad
Keyword(s):  
Enzymatic Hydrolysis ◽  
Antioxidant Capacity ◽  
Inhibitory Activity ◽  
Bioactive Peptides ◽  
Milk Proteins ◽  
Buffalo Milk ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Angiotensin I Converting Enzyme ◽  
Hydrolysis Of

scholarly journals The analysis of Angiotensin-I Converting Enzyme (ACE) by maitake (Grifrola frondosa) mycelia

2021 ◽  
Vol 8 (2) ◽  
pp. 69-72
Author(s):  
Yuen Sim Kheng ◽  
Young Liew Jeng ◽  
Maryana Mohamad Nor ◽  
Geng Boon Jia
Keyword(s):  
Inhibitory Activity ◽  
Protein Concentration ◽  
Bioactive Peptides ◽  
Biological Properties ◽  
Degree Of Hydrolysis ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Hydrolysis Time ◽  
Angiotensin I Converting Enzyme ◽  
Freeze Dried

The Maitake (Grifola frondosa) is useful in treating diseases, specifically hypertension. Research on the maitake mycelia’s biological properties, nevertheless, are limited in the literature. This study aimed to (i) produce mushroom biomass adopting submerged fermentation, and (ii) investigate the Angiotensin-I Converting Enzyme inhibitory activity. Maitake mycelia’s yield after 14 days of fermentation under controlled conditions (approx. 1.32 g/L) were freeze-dried into powder and later were hydrolysed for analyses of Angiotensin-I Converting Enzyme inhibitory activity. Current results showed that the degree of hydrolysis increased in line with hydrolysis time, as the protein concentration for hydrolysed sample was 283.61 ± 7.14 µg/mL, however, the non-hydrolysed sample resulted in lesser protein content (46.76 ± 1.09 µg/mL). The hydrolysate maitake mycelia has higher Angiotensin-I Converting Enzyme inhibitory activity (46.48%) as compared to the non-hydrolysate maitake mycelia (20.19 ± 0.17%). This finding suggested maitake mycelia hydrolysate can be a source of potential bioactive peptides used in treating hypertension.

Angiotensin I-Converting Enzyme Inhibitory Activity of Gelatin Hydrolysates and Identification of Bioactive Peptides

2011 ◽  
Vol 59 (2) ◽  
pp. 552-558 ◽  
Author(s):  
Griet Herregods ◽  
John Van Camp ◽  
Nicole Morel ◽  
Bart Ghesquière ◽  
Kris Gevaert ◽  
...  
Keyword(s):  
Inhibitory Activity ◽  
Bioactive Peptides ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Angiotensin I Converting Enzyme

Antioxidant capacity and angiotensin I converting enzyme inhibitory activity of a melon concentrate rich in superoxide dismutase

2012 ◽  
Vol 135 (3) ◽  
pp. 1298-1302 ◽  
Author(s):  
Julie Carillon ◽  
Daniele Del Rio ◽  
Pierre-Louis Teissèdre ◽  
Jean-Paul Cristol ◽  
Dominique Lacan ◽  
...  
Keyword(s):  
Superoxide Dismutase ◽  
Antioxidant Capacity ◽  
Inhibitory Activity ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Angiotensin I Converting Enzyme
Sign in / Sign up

Export Citation Format

Share Document